22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
The EAT upheld an Employment Tribunal (ET) decision that the dismissal of a Probation Service Office...
Read More >
The Supreme Court has considered the law on severance of restrictive covenants, and further develope...
Read More >
Public company directors, who are under constant threat of claims, received welcome news earlier thi...
Read More >
SEXUAL HARASSMENT IN THE WORKPLACE: WHAT US: MULTI-STATE COMPANIES NEED TO KNOW - We include the 20...
Read More >
In December, the National Labor Relations Board (NLRB) issued a flurry of employer-friendly decision...
Read More >
For employees boisterously raising employment-related concerns on behalf of a larger group, when mig...
Read More >